Gosselies, September 16th 2016 – ImmunXperts SA today announced that Thibault Jonckheere joined the fast growing company as CEO. Simultaneously, the immunogenicity company increased its capital to further accelerate the development of its immuno-oncology and cell therapy services.
“ImmunXperts supports its partners in the evaluation of new drug candidates with a solid experimental platform for drug testing. Thibault’s experience in value adding business deals and his long stance in the biotech services business, adds to our scientific and partnering expertise.” commented Sofie Pattijn, founder and CTO of ImmunXperts.
Prior to joining ImmunXperts, Thibault Jonckheere was Chief Business Officer at MaSTherCell (BE), where he was instrumental in the set-up, development and subsequent international expansion of the stem-cell CMO business. Thibault holds a Master of Business Engineering from the Solvay Business School (BE).
“I am very happy to join ImmunXperts and to contribute to the fast growth of the company in the immunogenicity and immuno-oncology fields. I was compelled by the quality of the team and the will of all stakeholders to develop ImmunXperts as the go-to partner for robust and rapid drug testing – especially in the field of cancer and stem cells “, comments Thibault Jonckheere.
Philippe Janssens de Varebeke, Chairman of ImmunXperts, further explains: “We are delighted to have Thibault on board. By strengthening the corporate capital, all the elements are in place to accelerate ImmunXpert’s growth. ”
Over ImmunXperts
Founded in 2014, ImmunXperts provides immunogenicity and immune-oncology screening services, assessing all aspects of the immune responses in donors and patients, supporting its partners in the full development cycle of novel drugs, biotherapeutics and stem cell therapies. Through its ImmunAcademy, the company supports biopharma companies to set up and build out immunology screening tools.
